We also analyzed the CMap database and proposed HDAC inhibitor, protein synthesis inhibitor, retinoid receptor agonist, and VEGFR inhibitor for targeting COMP in colon cancer. The gene discussed is COMP; the disease is malignant colon neoplasm.